Expectations and values about expanded newborn screening: a public engagement study.

作者: Robin Z. Hayeems , Fiona A. Miller , Yvonne Bombard , Denise Avard , June Carroll

DOI: 10.1111/HEX.12047

关键词:

摘要: Objectives Newborn bloodspot screening (NBS) panels have expanded to include conditions for which treatment effects are less certain, creating debate about population-based criteria. We investigated Canadian public expectations and values regarding the types of that should be included in NBS whether parents provide consent. Methods Eight focus groups (FG; n = 60) education, deliberative discussion pre-/post-questionnaires. Data were analysed quantitatively qualitatively. Results Quantitatively, majority supported serious disorders is not available (95–98, 82%). A endorsed without explicit consent (77–88%) treatable disorders, but 62% unpressured choice untreatable disorders. Qualitatively, participants valued treatment-related benefits infants informational families. Concern anxiety, stigma unwanted knowledge depended upon disease context strength countervailing benefits.

参考文章(53)
Angela E. Raffle, J. A. Muir Gray, Screening: Evidence and practice ,(2007)
M. A. Baily, T. H. Murray, E. W. Clayton, Lessons to be learned from the move toward expanded newborn screening. Ethics and newborn genetic screening: new technologies, new challenges. pp. 125- 135 ,(2009)
Mary Ann Baily, Thomas H. Murray, Ethics and newborn genetic screening : new technologies, new challenges Ethics and newborn genetic screening: new technologies, new challenges.. ,(2009)
James Maxwell Glover Wilson, Gunnar Jungner, World Health Organization, None, Principles and practice of screening for disease ,(1968)
Hans Zellweger, Alan Antonik, Newborn screening for Duchenne muscular dystrophy. Pediatrics. ,vol. 55, pp. 30- 34 ,(1975)
Kathleen Atkinson, Barry Zuckerman, Joshua M. Sharfstein, Donna Levin, Robin J.R. Blatt, Howard K. Koh, A public health response to emerging technology: expansion of the Massachusetts newborn screening program. Public Health Reports. ,vol. 116, pp. 122- 131 ,(2001) , 10.1093/PHR/116.2.122
Cheryl R. Greenberg, Hans K. Jacobs, William Halliday, Klaus Wrogemann, Three years' experience with neonatal screening for Duchenne/Becker muscular dystrophy: gene analysis, gene expression, and phenotype prediction American Journal of Medical Genetics. ,vol. 39, pp. 68- 75 ,(1991) , 10.1002/AJMG.1320390115